Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Farampator> ?p ?o. }
Showing items 1 to 60 of
60
with 100 items per page.
- Farampator abstract "Farampator (CX-691, Org 24448) is an ampakine drug. It was developed by Cortex Pharmaceuticals, and licensed to Organon BioSciences for commercial development. Following the purchase of Organon by Schering-Plough in 2007, the development license to farampator has been transferred, and development is continuing.Farampator has been investigated for its effect on AMPA receptors and researched for potential use in the treatment of schizophrenia and Alzheimer's Disease. It was found to improve short-term memory, but impaired episodic memory. It produced side effects (SEs) such as headache, somnolence and nausea. Subjects with SEs had significantly higher plasma levels of farampator than subjects without SEs. Additional analyses revealed that in the farampator condition the group without SEs showed a significantly superior memory performance relative to the group with SEs.".
- Farampator atcPrefix "none".
- Farampator casNumber "211735-76-1".
- Farampator fdaUniiCode "7X6P5N8K2L".
- Farampator iupacName "2,1,3-benzoxadiazol-6-yl-piperidin-1-ylmethanone".
- Farampator pubchem "4118151".
- Farampator thumbnail Farampator.svg?width=300.
- Farampator wikiPageID "9193207".
- Farampator wikiPageRevisionID "556265503".
- Farampator atcPrefix "none".
- Farampator c "12".
- Farampator casNumber "211735".
- Farampator chemspiderid "3331565".
- Farampator h "13".
- Farampator hasPhotoCollection Farampator.
- Farampator inchi "1".
- Farampator inchikey "XFVRBYKKGGDPAJ-UHFFFAOYAV".
- Farampator iupacName "213".
- Farampator kegg "D04131".
- Farampator legalStatus "Investigational New Medicine".
- Farampator molecularWeight "231.25052".
- Farampator n "3".
- Farampator o "2".
- Farampator pubchem "4118151".
- Farampator smiles "C1CCNCC2=CC3=NON=C3C=C2".
- Farampator stdinchi "1".
- Farampator stdinchikey "XFVRBYKKGGDPAJ-UHFFFAOYSA-N".
- Farampator synonyms "Farampator, CX-691".
- Farampator unii "7".
- Farampator verifiedfields "changed".
- Farampator verifiedrevid "406196055".
- Farampator width "180".
- Farampator subject Category:Amides.
- Farampator subject Category:Ampakines.
- Farampator subject Category:Benzoxadiazoles.
- Farampator subject Category:Piperidines.
- Farampator type Abstraction100002137.
- Farampator type Amide114724264.
- Farampator type Amides.
- Farampator type Chemical114806838.
- Farampator type Compound114818238.
- Farampator type Material114580897.
- Farampator type Matter100020827.
- Farampator type OrganicCompound114727670.
- Farampator type Part113809207.
- Farampator type PhysicalEntity100001930.
- Farampator type Relation100031921.
- Farampator type Substance100019613.
- Farampator type Drug.
- Farampator type DrugProduct.
- Farampator type FunctionalSubstance.
- Farampator comment "Farampator (CX-691, Org 24448) is an ampakine drug. It was developed by Cortex Pharmaceuticals, and licensed to Organon BioSciences for commercial development. Following the purchase of Organon by Schering-Plough in 2007, the development license to farampator has been transferred, and development is continuing.Farampator has been investigated for its effect on AMPA receptors and researched for potential use in the treatment of schizophrenia and Alzheimer's Disease.".
- Farampator label "Farampator".
- Farampator sameAs m.03w99q6.
- Farampator sameAs Q5434818.
- Farampator sameAs Q5434818.
- Farampator sameAs Farampator.
- Farampator wasDerivedFrom Farampator?oldid=556265503.
- Farampator depiction Farampator.svg.
- Farampator isPrimaryTopicOf Farampator.
